249 related articles for article (PubMed ID: 27856285)
1. Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke.
Li Y; Wu KJ; Yu SJ; Tamargo IA; Wang Y; Greig NH
Exp Neurol; 2017 Feb; 288():104-113. PubMed ID: 27856285
[TBL] [Abstract][Full Text] [Related]
2. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
3. The glucagon-like peptide-1 receptor agonist oxyntomodulin enhances beta-cell function but does not inhibit gastric emptying in mice.
Maida A; Lovshin JA; Baggio LL; Drucker DJ
Endocrinology; 2008 Nov; 149(11):5670-8. PubMed ID: 18669601
[TBL] [Abstract][Full Text] [Related]
4. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
Li Y; Tweedie D; Mattson MP; Holloway HW; Greig NH
J Neurochem; 2010 Jun; 113(6):1621-31. PubMed ID: 20374430
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucagon-like peptide 1 and oxyntomodulin on neuronal activity of ghrelin-sensitive neurons in the hypothalamic arcuate nucleus.
Riediger T; Eisele N; Scheel C; Lutz TA
Am J Physiol Regul Integr Comp Physiol; 2010 Apr; 298(4):R1061-7. PubMed ID: 20147608
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture.
Gharibani PM; Modi J; Pan C; Menzie J; Ma Z; Chen PC; Tao R; Prentice H; Wu JY
Adv Exp Med Biol; 2013; 776():241-58. PubMed ID: 23392887
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor.
Sowden GL; Drucker DJ; Weinshenker D; Swoap SJ
Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R962-70. PubMed ID: 17038440
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke.
Nizari S; Basalay M; Chapman P; Korte N; Korsak A; Christie IN; Theparambil SM; Davidson SM; Reimann F; Trapp S; Yellon DM; Gourine AV
Basic Res Cardiol; 2021 May; 116(1):32. PubMed ID: 33942194
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of oxyntomodulin and GLP-1 on glucose metabolism.
Du X; Kosinski JR; Lao J; Shen X; Petrov A; Chicchi GG; Eiermann GJ; Pocai A
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E265-71. PubMed ID: 22621866
[TBL] [Abstract][Full Text] [Related]
10. A novel GIP-oxyntomodulin hybrid peptide acting through GIP, glucagon and GLP-1 receptors exhibits weight reducing and anti-diabetic properties.
Bhat VK; Kerr BD; Flatt PR; Gault VA
Biochem Pharmacol; 2013 Jun; 85(11):1655-62. PubMed ID: 23518155
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 inhibits insulinotropic effects of oxyntomodulin and glucagon in cattle.
ThanThan S; Saito T; Yannaing S; Zhao H; Nakashima K; Kuwayama H
Domest Anim Endocrinol; 2012 Apr; 42(3):155-64. PubMed ID: 22154917
[TBL] [Abstract][Full Text] [Related]
12. Oxyntomodulin attenuates exendin-4-induced hypoglycemia in cattle.
ThanThan S; Asada Y; Saito T; Ochiiwa K; Zhao H; Yannaing S; Kuwayama H
Domest Anim Endocrinol; 2013 Feb; 44(2):70-80. PubMed ID: 23122871
[TBL] [Abstract][Full Text] [Related]
13. Calmodulin kinase IV-dependent CREB activation is required for neuroprotection via NMDA receptor-PSD95 disruption.
Bell KF; Bent RJ; Meese-Tamuri S; Ali A; Forder JP; Aarts MM
J Neurochem; 2013 Jul; 126(2):274-87. PubMed ID: 23363435
[TBL] [Abstract][Full Text] [Related]
14. Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminus.
Lynch AM; Pathak N; Flatt YE; Gault VA; O'Harte FP; Irwin N; Flatt PR
Eur J Pharmacol; 2014 Nov; 743():69-78. PubMed ID: 25246014
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway.
Liu C; Wu J; Xu K; Cai F; Gu J; Ma L; Chen J
J Neurochem; 2010 Mar; 112(6):1500-12. PubMed ID: 20050973
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular administration of chicken oxyntomodulin suppresses food intake and increases plasma glucose and corticosterone concentrations in chicks.
Honda K; Saneyasu T; Yamaguchi T; Shimatani T; Aoki K; Nakanishi K; Kamisoyama H
Neurosci Lett; 2014 Apr; 564():57-61. PubMed ID: 24530259
[TBL] [Abstract][Full Text] [Related]
17. (D-Ser2)Oxm[mPEG-PAL]: a novel chemically modified analogue of oxyntomodulin with antihyperglycaemic, insulinotropic and anorexigenic actions.
Kerr BD; Flatt PR; Gault VA
Biochem Pharmacol; 2010 Dec; 80(11):1727-35. PubMed ID: 20735990
[TBL] [Abstract][Full Text] [Related]
18. GIF-0173 protects against cerebral infarction through DP1 receptor activation.
Thura M; Hokamura K; Yamamoto S; Maeda M; Furuta K; Suzuki M; Ibaraki K; Umemura K
Exp Neurol; 2009 Oct; 219(2):481-91. PubMed ID: 19576888
[TBL] [Abstract][Full Text] [Related]
19. Oxyntomodulin reduces expression of glucagon-like peptide 1 receptor in the brainstem of chickens.
Moghaddam AG; Yaghoobi MM; Jonaidi H; Mahani MT; Sepehri H
J Anim Physiol Anim Nutr (Berl); 2010 Aug; 94(4):422-8. PubMed ID: 19663977
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of calcitriol on ischemic/reperfusion injury through the NR3A/CREB pathways in the rat hippocampus.
Fu J; Xue R; Gu J; Xiao Y; Zhong H; Pan X; Ran R
Mol Med Rep; 2013 Dec; 8(6):1708-14. PubMed ID: 24141895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
